City

Boston (1)

Edmonton (1)

Lille (1)

Montreal (1)

Condition

Olfactory Disorders (3)

Anorexia (1)

Cancer (1)

End Stage Renal Disease (1)

Scleroderma (1)

Taste Disorders (1)

Overall Status

Completed (1)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

Sponsor

Alberta Health services (1)

Massachusetts General Hospital (1)

University Hospital, Lille (1)

Collaborator

University of Alberta (1)

Intervention

marinol (dronabinol) (1)

olfactory testing with specific odorants (localisation and identification) (1)

placebo (1)

theophylline (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

olfactory disorders

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Olfactory Disorders, Scleroderma Trial in Lille (olfactory testing with specific odorants (localisation and identification))

Terminated

Olfactory Disorders
Scleroderma

olfactory testing with specific odorants (localisation and identification)

Lille, France

Hop Claude Huriez Chu Lille

Nov 17, 2020

End Stage Renal Disease, Olfactory Disorders Trial in Boston (Theophylline)

Unknown status

End Stage Renal Disease
Olfactory Disorders

Theophylline

Boston, Massachusetts

Massachusetts General Hospital

Aug 31, 2020

Cancer, Anorexia, Taste Disorders Trial in Edmonton, Montreal (Marinol (Dronabinol), Placebo)

Completed

Cancer
+3 more

Marinol (Dronabinol)
Placebo

Edmonton, Alberta, Canada
+1 more

Feb 8, 2010